News
RSA Insight: The impacts of delayed early screening diagnoses on cancer treatment results due to Covid-19
RSA recognizes the impact Covid-19 has made on families and individuals regarding their decisions for preventative testing and cancer treatment. Learn more about our stance on best practices.
RSA Is Proud to Announce ISO 9001:2015 Certification
RSA is excited to announce that they have been awarded the ISO 9001:2015 certification, an internationally recognized standard that ensures their products and services meet or exceed the needs of...
Teledyne e2V and RS&A, a partnership that will change lives.
Teledyne e2V and RS&A are partnering together to create lasting change in the field of radiation oncology. We are dedicated to supporting our customers, delivering new research and educational resources, and building a...